Acute pancreatitis - The current status in management

Expert Opinion on Pharmacotherapy

Volumn 4, Issue 2, 2003, Pages 235-241

  Nam, Jong H ^a   Murthy, Sreekant ^a  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

Acute pancreatitis; Cykotine inhibitors; Cykotines; Diagnosis; Mechanisms; Pancreatitis; Pathogenesis; Treatment

Indexed keywords

AMYLASE; ANTIBIOTIC AGENT; ATROPINE; CALCITONIN; CALCIUM; CILASTATIN; CIMETIDINE; CYTOKINE; ELASTASE; GABEXATE; GLUCAGON; GLYCERYL TRINITRATE; IMIPENEM; INOTROPIC AGENT; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; KALLIKREIN; LEXIPAFANT; LIPID; OCTREOTIDE; PHOSPHOLIPASE A2; PLACEBO; PROTEIN INHIBITOR; PROTEINASE INHIBITOR; SOMATOSTATIN DERIVATIVE; THROMBOCYTE ACTIVATING FACTOR; THROMBOCYTE ACTIVATING FACTOR ANTAGONIST; TRIACYLGLYCEROL LIPASE; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR ANTIBODY; UNINDEXED DRUG;

ACUTE PANCREATITIS; ALCOHOL CONSUMPTION; BILIARY TRACT ENDOSCOPY; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CYTOKINE RELEASE; DISEASE ASSOCIATION; DRUG EFFICACY; ECHOGRAPHY; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; ENZYME INHIBITION; EUROPE; GALLSTONE; HEMODIALYSIS; HUMAN; HYPERCALCEMIA; HYPERLIPIDEMIA; HYPOTENSION; INCIDENCE; INTENSIVE CARE; MONONUCLEAR CELL; MORBIDITY; MORTALITY; MULTIPLE ORGAN FAILURE; NONHUMAN; PANCREAS DISEASE; PANCREAS SECRETION; PATHOGENESIS; PATIENT CARE; PEPTIC ULCER; REVIEW; SENSITIVITY AND SPECIFICITY; STOMACH SUCTION; UNITED KINGDOM; UNITED STATES; VATER PAPILLOTOMY;

EID: 0037329824     PISSN: 14656566     EISSN: None     Source Type: Journal    
DOI: 10.1517/14656566.4.2.235     Document Type: Review

References (66)

1. BRADLEY EL III: A clinically based classification system for acute pancreatitis. Arch. Surg. (1993) 128:586-590.
2. TOOULI J, BROOKE-SMITH M, BASSI C et al.: Guidelines for the management of acute pancreatitis. J. Gastroenterol. Hepatol. (2002) 17:S15-S39.
3. AMMANN RW, AKOVBIANTZ A, LARGIADER F, SCHUELER G: Course and outcome of chronic pancreatitis: longitudinal study of a mixed medical-surgical series of 245 patients. Gastroenterology (1984) 86:820-828.
4. MIYAKE H, HARADA H, KUNICHIKA K, OCHI K, KIMURA I: Clinical course and prognosis of chronic pancreatitis. Pancreas (1987) 2:378-385.
5. LANKISCHE PG, LOHR-HAPPE A, OTTO J, CREUTZFELDT W: Natural course in chronic pancreatitis: pain, exocrine and endocrine pancreatic insufficiency and prognosis of the disease. Digestion (1993) 54:148-155.
6. STEER ML, WAXMAN I, FREEDMAN S: Chronic pancreatitis. N. Engl. J. Med. (1995) 332:1482-1490.
7. FOITZIK T, KLAR E, BUHR HJ, HERFARTH C: Improved survival in acute pancreatitis despite limiting the indications for surgical debridement. Eur. J. Surg. (1995) 161:187-192.
8. BARON TH, MORGAN DE: Acute necrotizing pancreatitis. N. Engl. J Med. (1999) 340:1412-1417.
9. TRAPNELL JE, DUNCAN EH: Patterns of incidence in acute pancreatitis. Br. Med. J. (1975) 2:179-183.
10. JAAKKOLA M, NORDBACK I: Pancreatitis in Finland between 1970 and 1989. Gut (1993) 34:1255-1260.
11. GO VLW: Etiology and epidemiology of pancreatitis in the United States. In: Acute Pancreatitis. Diagnosis and Therapy Bradley EL III (Ed). Raven Press, NY, USA (1994) 235-239.
12. WILSON C, IMRIE CW: Changing patterns of incidence and mortality from acute pancreatitis in Scotland, 1961-1985. Br. J. Surg. (1990) 77:731-734.
13. MCKAY CJ, EVANS S, SINCLAIR M: High early mortality rate from acute pancreatitis in Scotland, 1984-95. Br. J. Surg. (1999) 86:1302-1305.
14. STEINBERG W, TENNER S: Acute pancreatitis. N. Engl. J. Med. (1994) 330:1198-1210.
15. ROS E, NAVARRO S, BRU C: Occult microlithiasis in 'idiopathic acute pancreatitis: prevention of relapses by cholecystectomy or ursodeoxycholic acid therapy. Gastroenterology (1991) 101:1701-1709.
16. LEE SP, NICHOLLS JF, PARK HZ: Biliary sludge as a cause of acute pancreatitis. N. Engl. J. Med. (1992) 326:589-593.
17. GARG PK, GOINDI G, TANDON RK: Stimulation of gallbladder by intravenous infusion of amino acids: a new method to obtain duodenal bile for bile analyses. Dig. Dis. Sci. (2000) 45:904-908.
18. TANDON M, TOPAZLAN M: Endoscopic ultrasound in idiopathic acute pancreatitis. Am. J. Gastroenterol. (2001) 96:705-709.
19. BANKS PA: Acute and chronic pancreatitis. In: Feldman: Sleisenger & Fordtran's Gastrointestinal and Liver Disease (6th edn). Feldman M, Scharschmidt BF, Slisenger MH, Fordtran JS, Zorab R. WB Saunders, Philadelphia, PA (1998):809-838.
20. BUCHLER M, MALFERTHEINER P, SCHADLICH H, NEVAALLAINEN TJ, FRIESS H, BEGER HG: Role of phospholipase A in human acute pancreatitis. Gastroenterology (1989) 97:1521-1526.
21. NORMAN J: The role of cytokines in the pathogenesis of acute pancreatitis. Am. J. Surg. (1998) 175:76-83.
22. NORMAN J, FINK G, FRANZ M: Acute pancreatitis induces intrapancreatic tumor necrosis factor gene expression. Arch. Surg. (1995) 130:966-970.
23. BLINMAN TA, GUKOVSKY IY, GUKOVSKAYA S et al.: Pancreatic acinar cells express a variety of cytokines that are regulated in experimental pancreatitis. Gastroenterology (1997) 112:A429.
24. FINK G, NORMAN J: Pancreatitis induces specific changes in the intrapancreatic expression of the TNF family of genes. Pancreas (1995) 11:428A.
25. BIFFL WL, MOORE EE, MOORE FA: Interleukin-6 in the injured patients. Marker of injury or mediator of inflammation. Ann. Surg. (1996) 224:647-664.
26. KISHIMOTO T, AKIRA S, NARAZAKI M: Interleukin-6 family of cytokines and gp130. Blood (1995) 86:1243-1254.
27. BAGGIOLINI M, LOETSCHER P, MOSER B: Interleukin-8 and the chemokine family. Int. J. Immunopharmac. (1995) 17:103-108.
28. GROSS V, ANDERSEN R, LESER HG: Interleukin-8 and neutrophil activation in acute pancreatitis. Eur. J. Clin. Invest. (1992) 22:200-203.
29. KINGSNORTH A: Role of cytokines and their inhibitors in acute pancreatitis. Gut (1997) 40:1-4.
30. ABU-ZIDAN FM, BONHAM MJD, WINDSOR JA: Severity of acute pancreatitis: a multivariate analysis of oxidative stress markers and modified Glasgow criteria. Br. J. Surg. (2000) 87:1019-1023.
31. BONHAM MJD, ABU-ZIDAN FM, SIMOVIC MO et al.: Early ascorbic acid depletion is related to the severity of acute pancreatitis. Br. J. Surg. (1999) 86:1296-1301.
32. BANKS PA: Practice guidelines in acute pancreatitis. Am. J. Gastroenterol. (1997) 92:377-386.
33. UHL W, BUCHLER MW, MALFERTHEINER P, BEGER HG, ADLER G: A randomized, double blind, multicentre trial of octreotide in moderate to severe acute pancreatitis. Gut (1999) 45:97-104.
34. WISNER JR, RENNER IG, GRENDELL JH, NIEDERAU C, FERRELL LD: Gabexate mesilate (FOY) protects against ceruletide-induced acute pancreatitis in rats. Pancreas (1987) 2:181-186.
35. OHSHIDO G, SALUJA AK, LELI U, SENGUPTA A, STEER ML: Esterase inhibitors prevent lysosomal enzyme redistribution in two noninvasive models of experimental pancreatitis. Gastroenterology (1989) 96:853-859.
36. BUCHLER M, MALFERTHEINER P, UHL W et al.: Gebexate mesilate in human acute pancreatitis. German Pancreatitis Study Group. Gastroenterology (1993) 104:1165-1170.
37. CAVALLINI G, TITTOBELLO A, FRULLONI L, MASCI E, MARIANI A, DI FRANCESCO V: Gabexate for the prevention of pancreatic damage related to endoscopic retrograde cholangiopancreatography. N. Engl. J. Med. (1996) 335:919-923.
38. KONTUREK SJ, DEMBINSKI A, KONTUREK PJ: Role of platelet activating factor in pathogenesis of acute pancreatitis in rats. Gut (1992) 33:1268-1274.
39. FORMELA SJ, WOOD LM, WHITTAKER M: Amelioration of experimental acute pancreatitis with a potent platelet activating factor antagonist. Br. J. Surg. (1994) 31:1783-1785.
40. KINGSNORTH AN, GALLOWAY SW, FORMELA LJ: Randomized, double-blind Phase II trial of lexipafant, a platelet activating factor antagonist, in human acute pancreatitis. Br. J. Surg (1995) 82:1414-1420.
41. MCKAY C, CURRAN FJM, SHARPLES CE: Prospective placebo-controlled randomized trial of lexipafant in predicted severe acute pancreatitis. Br. J. Surg. (1997) 84:1239-1243.
42. JOHNSON CD, KINGSNORTH AN, IMRIE CW et al.: Double blind, randomized, placebo controlled study of a platelet activating factor antagonist, lexipafant, in the treatment and prevention of organ failure in predicted severe acute pancreatitis. Gut (2001) 48:62-69.
43. HUGHES CB, GREVAL HP, GABER LW, et al.: Anti-TNF-α therapy improves survival and ameliorates the pathophysiologic sequelae in acute pancreatitis in the rat. Am. J. Surg. (1996) 171:274-280.
44. OSMAN MO, KRISTENSEN JU, JACOBSEN NO et al.: A monoclonal anti-interleukin 8 antibody (WS-4) inhibits cytokine response and acute lung injury in experimental severe acute necrotizing pancreatitis in rabbits. Gut (1998) 43:232-239.
45. NORMAN J, FRANZ M, MESSINA J, RIKER A, FABRI PJ, ROSMURGY AS: Interleukin-1 receptor antagonist decreases severity of experimental acute pancreatitis. Surgery (1995) 117:648-655.
46. TANAKA N, MURATA B, UDA K, TODA H, KATO T, HAYASHIDA H: Interleukin-1 receptor antagonist modifies the changes in vital organs induced by acute necrotizing pancreatitis in a rat experimental model. Crit. Care Med. (1995) 23:910-918.
47. STARITZ M, PORALLA, EWE K, MEYER ZUM BUSCHENFELDE KH: Effect of glyceryl trinitrate on the sphincter of Oddi motility and baseline pressure. Gut (1985) 26:194-197.
48. STARIZ M, PORALLA T, DORMEYER HH, MEYER ZUM BUSCHENFELDE KH: Endoscopic removal of common bile duct stones through the intact papilla after medical sphincter dilatation. Gastroenterology (1985) 88:1807-1811.
49. SUDHINDRAN S, BROMWICH E, EDWARDS PR: Prospective randomized double-blind placebo-controlled trial of glycerol trinitrate in endoscopic retrograde cholangiopancreatography-induced pancreatitis. Br. J. Surg. (2001) 88:1178-1182.
50. NEOPTOLEMOS JP, CARR-LOCKE DL, LONDON NJ: Controlled trial of urgen endoscopic retrograde cholangiopancreatography and endoscopic sphincterotomy versus conservative treatment for acute pancreatitis due to gallstones. Lancet (1988) 2:979-983.
51. FAN ST, LAI EC, MOK FP: Early treatment of acute biliary pancreatitis by endoscopic papillotomy. N. Engl. J. Med. (1993) 328:228-232.
52. FOLSCH UR, NITSCHE R, LUDTKE R: Early ERCP and papillotomy compared with conservative treatment for acute biliary pancreatitis. The German Study Group on Acute Biliary Pancreatitis. N. Engl. J. Med. (1997) 336:237-242.
53. NOWAK A, MAREK TA, NOWAKOWSKA-DULAWA E: Biliary pancreatitis needs endoscopic retrograde cholangiopancreatography with endoscopic sphincterotomy for cure. Endoscopy (1998) 30:A256-A259.
54. SHARMA VK, HOWDEN CW: Metaanalysis of randomized controlled trials of endoscopic retrograde cholangiopancreatography and endoscopic sphincterotomy for the treatment of acute biliary pancreatitis. Am. J. Gastroenterol. (1999) 94:3211-3214.
55. KEMPPAINEN EA, HEDSTROM JI, PUOLAKKAINEN PA et al.: Rapid measurement of urinary trypsinogen-2 as a screening test for acute pancreatitis. N. Engl. J. Med. (1997) 336:1788-1793.
56. NEOPTOLEMOS JP, KEMPPAINEN EA, MAYER JM et al.: Early prediction of severity in acute pancreatitis by urinary trypsinogen activation peptide: a multicentre study. Lancet (2000) 335:1955-1960.
57. KHAN Z, VLODOV J, HOROVITZ J, et al.: Urinary trypsinogen activation peptide is more accurate than hemocrit in determining severity in patients with acute pancreatitis: a prospective study. Am. J. Gastroenterol. (2002) 97:1973-1977.
58. FOITZIK T, FERNANDE-DEL CASTILLO C, FERRARO MJ, MITHOFER K, RATTNER DW, WARSHAW AL: Pathogenesis and prevention of early pancreatic infection in experimental acute necrotizing pancreatitis. Ann. Surg. (1995) 222:179-185.
59. MITHOFER K, FERNANDEZ-DEL CASTILLO C, FERRARO MJ, LEWANDROWKI K, RATTNER DW, WARSHAW AL: Antibiotic treatment improves survival in experimental acute necrotizing pancreatitis. Gastroenterology (1996) 110:232-240.
60. LUITEN EJ, HOP WC, LANGE JF, BRUINING HA: Controlled clinical trial of selective decontamination for the treatment of severe acute pancreatitis. Ann. Surg. (1995) 222:57-65.
61. LUITEN EJ, HOP WC, LANGE JF, BRUINING HA: Differential prognosis of Gram-negative versus Gram-positive infected and sterile pancreatic necrosis: results of a randomized trial in patients with severe acute pancreatitis treated with adjuvant selective decontamination. Clin. Infect. Dis. (1997) 25:811-816.
62. PEDERZOLI P, BASSI C, VESENTINI S, CAMPEDELLI A: A randomized multicentre clinical trial of antibiotic prophylaxis of septic complications in acute necrotizing pancreatitis with imipenem. Surg. Gynecol. Obstet. (1993) 176:480-483.
63. HO HS, FREY CE: The role of antibiotic prophylaxis in severe acute pancreatitis. Arch. Surg. (1997) 132:487-493.
64. NAKAD A, PIESSEVAUS H, MAROT JC: Is early enteral nutrition in acute pancreatitis dangerous? About 20 patients fed by an endoscopically placed nasogastrojejunal tube. Pancreas (1998) 17:187-193.
65. MCCLAVE SA, GREENE LM, SNIDER HL: Comparison of the safety of early enteral versus parenteral nutrition in mild acute pancreatitis. J. Paren. Enteral. Nutr. (1997) 21:14-20.
66. KALFARENTZOS F, KEHAGIAS J, MEAD N: Enteral nutrition is superior to parenteral nutrition in severe acute pancreatitis: results of a randomized prospective trial. Br. J. Surg. (1997) 84:1665-1669.